Pay in 4 interest-free payments of $6.01 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
The latest study included nearly 100,000 participants, more than 20,000 of whom had used GLP-1 medications
Companies like Cigna, Aetna, and UnitedHealth Group leverage health data from consumers using GLP-1 drugs to reduce risk profiles and offer more targeted plans that reflect the specific needs of policyholders
Rami Bailony, an obesity specialist and CEO of Enara, who was not involved in the research, told MNT that his initial reaction was one of cautious interest as it is important to interpret the results in a broader context
serious adverse events
Its the latest GLP-1 drug to get approval for type 2 diabetes (under the name Mounjaro) and weight loss (under the name Zepbound)
Interestingly, GLP-1 has proliferative and antiapoptotic actions on pancreatic -cells [24, 25], and has neurotrophic and neuroprotective features [21]
US$ 28.80
US$ 28.17
US$ 20.87
US$ 28.73
US$ 29.89
US$ 22.88
US$ 20.86
US$ 23.35
US$ 28.99
